Succession of the Organic Acid Facilities at the Kashima Plant and Construction of Malic Acid Production Facilities
First written in FY2016. 8 of 18 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2023-Q2.
No other company in this theme has enough history to compare yet.
- FY2023-Q2RestatedAnnual report
「Malic acid exports also continued to perform steadily, and net sales increased, partly due to price revisions and the weaker yen.」
Exports have continued to expand following the start-up of the new Kashima malic acid facilities, but no new milestones, such as the completion of additional facilities, have been indicated. - FY2023-Q1RestatedAnnual report
「Malic acid exports also increased steadily, and net sales increased, partly due to the weaker yen.」
The business benefit of increased exports following the start of full-scale operations at the new Kashima malic acid facilities continues to be described. - FY2022AdvancedAnnual report
「In fiscal 2021, the malic acid plant at the Kashima Site completed acquisition of the international FSSC22000 certification, continued full-scale commercial continuous production, and established its structure as the main plant.」
Following construction and the start-up of the malic acid facilities, the business has advanced to the stage of obtaining international certification, conducting full-scale commercial continuous production, and establishing the main-plant structure. - FY2022-Q3AdvancedAnnual report
「Malic acid sales, mainly exports, increased substantially following the start-up of the new malic acid facilities at the Kashima Site, and net sales increased, partly due to the weaker yen.」
The document describes the business benefit of a substantial increase in malic acid sales, mainly exports, following the start of full-scale operations at the new Kashima malic acid facilities. - FY2022-Q2AdvancedAnnual report
「Malic acid sales, mainly exports, continued to perform steadily following the start-up of the new malic acid facilities at the Kashima Site, and net sales increased, also benefiting from the weaker yen.」
The business benefit of increased malic acid sales, mainly exports, has continued following the start of full-scale operations at the new Kashima malic acid facilities. - FY2022-Q1AdvancedAnnual report
「Exports of malic acid have increased steadily following the start-up of the new malic acid facilities at the Kashima Site, and net sales increased, partly due to the weaker yen.」
The document describes the business benefit of increased exports following the start-up of the new Kashima malic acid facilities in January 2021. - FY2021AdvancedAnnual report
「The new malic acid production facilities at the Kashima Site, completed in July 2019, have been in full-scale operation since January 2021. In fiscal 2021 (the fiscal year ending March 2022), we will work to strengthen process controls and take other measures with the aim of maintaining stable operations throughout the year.」
The completed Kashima malic acid facilities began full-scale operations in January 2021, advancing to the stage of stable year-round operations and strengthened process controls. - FY2020AdvancedAnnual report
「The new malic acid plant at the Kashima Site was completed in July 2019.」
The malic acid production facilities were completed. The equipment plan has been updated to a total planned investment amount of ¥5,456 million and an amount already paid of ¥4,921 million, and preparations for full-scale operations are continuing. - FY2020-Q3Equipment plan updatedAnnual report
「Kashima Site Life Science Business Construction of new malic acid production facilities (Note) 1 5,800 3,177 Internal funds (Note) 3 2017年11月 2019年7月」
The plan for the construction of new malic acid production facilities at the Kashima Site has been updated to a planned investment amount of ¥5,800 million, an amount already paid of ¥3,177 million, and scheduled completion in 2019年7月. The amount already paid increased from ¥3,176 million in the previous disclosure. - FY2020-Q1Equipment plan updatedAnnual report
「Kashima Site Life Science Business Construction of new malic acid production facilities 5,800 3,176 Internal funds 2017年11月 2019年7月」
The plan for the construction of new malic acid production facilities has been updated to a planned investment amount of ¥5,800 million, an amount already paid of ¥3,176 million, and scheduled completion in 2019年7月. - FY2019Equipment plan updatedAnnual report
「Kashima Site Life Science Business Construction of new malic acid production facilities 5,800 3,175 Internal funds 2017年11月 2019年7月」
The plan for the construction of new malic acid production facilities has been updated to a planned investment amount of ¥5,800 million, an amount already paid of ¥3,175 million, and scheduled completion in 2019年7月. - FY2019-Q3Equipment plan updatedAnnual report
「Kashima Site Life Science Business Construction of new malic acid production facilities 5,800 3,169 Internal funds November 2017 July 2019」
For the construction of new malic acid production facilities at the Kashima Site, the plan states a planned investment amount of ¥5,800 million, an amount already paid of ¥3,169 million, and scheduled completion in July 2019. The amount already paid has been updated from the previous disclosure. - FY2019-Q2Equipment plan updatedAnnual report
「Kashima Site Life Science Business Construction of new malic acid production facilities 5,800 1,585 Internal funds November 2017 July 2019」
For the construction of new malic acid production facilities at the Kashima Site, the plan states a planned investment amount of ¥5,800 million, an amount already paid of ¥1,585 million, and scheduled completion in July 2019. - FY2018AdvancedAnnual report
「In addition, we will work to make a major advance from Japan's only manufacturer to the world's No. 1 malic acid manufacturer.」
Construction of the new malic acid plant at the Kashima Site began in March 2018. The equipment plan called for a planned investment amount of ¥5,800 million and completion in July 2019, and an integrated production structure from malic acid raw materials through finished products was also established at the Kashima Site. - FY2018-Q3AdvancedAnnual report
「On 1 November 2017, we completed the transfer of the Kashima Site from Mitsui Chemicals,Inc. and the transfer of the organic acids business. On 1 November 2017, we also took over the Kashima Site from Mitsui Chemicals,Inc. and began operations there as the core production base of the Life Science Business.」
The transfer of the organic acids business at the Kashima Site was completed on 1 November 2017, and operations began as the core production base of the Life Science Business. Meanwhile, the construction plan for the malic acid production facilities continued separately. - FY2018-Q2RaisedAnnual report
「The planned investment amount has increased by ¥2,200 million because additional functions are planned to further pursue stable production and greater production efficiency compared with the initial investment plan. The scheduled completion date has also changed.」
For the construction of new malic acid production facilities at the Kashima Site, the planned investment amount increased by ¥2,200 million due to the addition of functions, bringing the total to ¥5,800 million, and completion was scheduled for July 2019. - FY2017-Q2Changes to the equipment investment scheduleAnnual report
「The scheduled start and completion dates have changed.」
The organic acids production facilities at the Kashima Plant were scheduled to start construction in November 2017 and be completed in December 2017, while the new malic acid production facilities were scheduled to start construction in November 2017 and be completed in March 2019. The scheduled start and completion dates have changed from the previous plan. - FY2016First statedAnnual report
「The transfer of the production facilities at the Kashima Plant, the main plant of the organic acids business acquired from Mitsui Chemicals,Inc., was scheduled for completion by the end of 2017. In addition, construction of malic acid production facilities at the Kashima Plant was planned, with a target of commencing operations during fiscal 2018.」
The acquisition of the organic acids production facilities at the Kashima Plant was planned at an investment amount of ¥1 billion, while the construction of new malic acid production facilities was planned at ¥3.6 billion. Both were to be funded with proceeds from the capital increase and other sources.